JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

China flag China · Delayed Price · Currency is CNY
26.88
-0.51 (-1.86%)
Mar 9, 2026, 4:00 PM EDT
4.19%
Market Cap 11.70B
Revenue (ttm) 2.23B
Net Income (ttm) 617.04M
Shares Out 435.17M
EPS (ttm) 1.42
PE Ratio 18.93
Forward PE n/a
Dividend 0.68 (2.48%)
Ex-Dividend Date Jun 17, 2025
Volume 1,240,394
Average Volume 776,707
Open 27.06
Previous Close 27.39
Day's Range 26.77 - 27.19
52-Week Range 25.61 - 30.86
Beta 0.44
RSI 53.13
Earnings Date Apr 24, 2026

About SHA:603235

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, α-acetyl-γ-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China. [Read more]

Industry Packaged Foods
Founded 2004
Employees 2,679
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603235
Full Company Profile

Financial Performance

In 2024, SHA:603235's revenue was 2.21 billion, an increase of 17.35% compared to the previous year's 1.88 billion. Earnings were 651.22 million, an increase of 36.85%.

Financial Statements

News

There is no news available yet.